SLC6A3 and schizophrenia: Research on striatal DAT availability in schizophrenia has yielded inconsistent findings (Brugger et al., 2020; Howes et al., 2012), and the link to cognitive impairment remains elusive due to a paucity of studies (Yang, Chen, Liu, Yang, & Chou, 2022a).